Brenzavvy Tablet
Product Images NDC 82381-2174

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brenzavvy (NDC 82381-2174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Theracosbio, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brenzavvy-figure-1 (Brenzavvy Figure 1)

A forest plot chart showing the geometric mean ratio with 90% confidence intervals for AUC and Cmax of various drugs including Metformin, Glimepiride, Sitagliptin, Exenatide, Probenecid, Verapamil, and Rifampin. The x-axis is labeled "Geometric Mean Ratio (90% CI)" and each drug's AUC and Cmax values are plotted as points with horizontal error bars.*

FDA Label Image

Brenzavvy-figure-2 (Brenzavvy Figure 2)

A forest plot displaying the geometric mean ratio (with 90% confidence intervals) of the pharmacokinetic parameters AUC and Cmax for BRENZAVVY (Bexagliflozin 20 mg tablet) when co-administered with various drugs: Metformin 1000 mg, Glimepiride 2 mg, Sitagliptin 100 mg, and Digoxin 0.5 mg. The x-axis is labeled 'Geometric Mean Ratio (90% CI)' with a reference line at 100.*

FDA Label Image

Brenzavvy-figure-3 (Brenzavvy Figure 3)

A line graph depicting mean percentage change over 24 weeks comparing BRENZAVVY (bexagliflozin) and placebo groups. The x-axis represents weeks (0 to 24), and the y-axis shows mean change in percentage. Data points for BRENZAVVY decrease significantly by week 12 and then stabilize, while placebo remains near baseline. The graph includes error bars and legends identifying treatment groups.*

FDA Label Image

Brenzavvy-label-30s (Brenzavvy Label 30s)

Label for Brenzavvy (bexagliflozin) oral tablets, 20 mg strength. The label indicates a package containing 30 tablets, distributed by TheracosBio, LLC, Marlborough, MA. It includes storage instructions, a barcode, and directions to dispense the enclosed Medication Guide to each patient.*

FDA Label Image

Brenzavvy-label-90s (Brenzavvy Label 90s)

Label for Brenzavvy (bexagliflozin) 20 mg oral tablets by TheracosBio, LLC. The label states 90 tablets per container with storage instructions, dosage caution, and dispensing guidance. It includes barcode and lot/expiry sections.*

FDA Label Image

Brenzavvy-structure (Brenzavvy Structure)

Chemical structure of Bexagliflozin, the active ingredient in BRENZAVVY 20 mg oral tablets by TheracosBio, LLC. The diagram shows the molecular arrangement including hydroxyl groups, aromatic rings, a chlorine atom, and a cyclopropyl ether moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.